A 3d-printer box that mixes peptide vials.
- 10 candidates = 10 vials
- first run: test peptides for the arm
- then: re-synthesises winning peptides for use
BIOS reads the literature, designs the binder,
and builds it in the lab.
Model a target, design a binder, and watch it fold on screen.
BIOS hardware turns the best designs into real vials, unattended.
A validated candidate becomes a therapy. The loop closes.
Three AI models generate candidates, then six filters cut a hundred designs down to the ten most likely to work — about 35 minutes and $8 of compute per run.
The design engine
Generate → 6 orthogonal filters → shortlist → wet lab
The core gate follows the Overath architecture: one DL confidence metric plus one orthogonal physicochemical descriptor, with cross-model agreement as the false-positive filter. Filters 1–4 are the fast core (<1 hr, <$7, mostly CPU). MD and ADMET are deeper validation that runs on the survivors.
Select an engine or filter for detail.
Run the whole pipeline from a single command, or call any tool inline: public databases, image segmentation, target analysis.
$ bios design --target GLP1R --n 100▍
100 designs3 engines6 filters~35 min$8 compute
Retrieve
Segment
Track
Analyze
Hardware closes the loop: a synthesis box mixes the top-ranked peptide vials and a dexterous robotic arm assays them on live cells, feeding every result back into the model.
A 3d-printer box that mixes peptide vials.
5-DOF arm + 21-DOF dexterous hand.
Nine stages, learning from every run.
iterative loop
$ bios design "a stable GLP-1R agonist" → ETA ~50 min
Ask a research question. BIOS plans the work, reads the papers, runs the analysis, and gives you a cited answer, then suggests what to do next. You steer.
BIOS breaks your question into steps and hands each one to the right agent.
It searches papers, patents, clinical trials, and biology databases for what matters.
Analysis agents run the numbers: Python, statistics, and data processing over the evidence.
Everything comes back as one cited answer you can question and refine.
BIOS proposes new directions and experiments, so each loop goes deeper.
Papers, lab notebooks, features we shipped, and the things that didn't work.
BIOS is an AI platform for drug discovery. From a single prompt it reads the literature, designs candidate protein binders with state-of-the-art models, filters them down to the most promising, and helps take them into the lab.
Three generative models (RFdiffusion3, BoltzGen, and PXDesign) propose candidates, then six orthogonal filters — structural confidence, cross-model agreement, physics energetics, selectivity, molecular dynamics, and developability — cut roughly a hundred designs down to the ten most likely to work.
BIOS runs open models including RFdiffusion3, Boltz-2, ESMFold2, mmseqs2, and Foldseek, all catalogued on the BIO Index (index.bio.xyz). It also exposes bioinformatics databases, image segmentation, and target-analysis tools inline.
A typical run turns about a hundred candidate designs into a shortlist of ten in roughly 35 minutes for about $8 of compute.
Yes. BIOS plans a research question into steps, searches papers, patents, clinical trials, and biology databases, runs the analysis, and returns one cited answer you can question and refine — then proposes new directions to explore.
You can start chatting with BIOS at chat.bio.xyz. For partnerships, demos, or research collaborations, reach the team through the contact page.